Stock screenerAll disclosures →
EDGAR →
BNTX
Conviction 25HealthcareScan · Mon, Aug 10, 2026BNTX$92.78-0.95%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 1.03M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price92.78
Change-0.95%
Gap+0.38%
Rel volume0.70×
Avg volume963.89K
Avg $ vol88.54M
SMA 2091.82
SMA 5091.37
SMA 20097.82
Price vs 50+1.55%
Price vs 200-5.16%
MA stackmixed
50/200 cross—
Supertrendup · 88.76
RSI (14)52
MACD hist0.12
MACD crossbull · 1d
Stoch %K / %D74 / 70
ADX (14)8
+DI / −DI18 / 17
RSI divergence—
MACD divergence—
ATR %+2.91%
ADR %2.81%
52w high119.34
52w low83.89
From 52w high-22.26%
Above 52w low+10.60%
New 52w highNo
SqueezeOn · 7d
Bollinger width4.24%
%B0.75
Donchian pos73.75%
Donchian high94.41
Donchian low88.20
AVWAP (52w high)94.84
vs AVWAP high-2.17%
AVWAP (52w low)91.80
vs AVWAP low+1.07%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d0.70×
Avg vol (14d)1.03M
Avg vol (20d)963.89K
Avg $ vol (20d)88.54M
Market cap23.46B
RS 3m (vs SPY)-5.00%
RS 6m (vs SPY)-25.36%
RS line new highNo
Trend template2/8
Technical rank35.8
1 week+0.57%
1 month+1.41%
3 months-1.43%
6 months-12.98%
1 year-16.68%
YTD-4.04%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target124.58
Target upside34.27%
Analyst ratingBuy
Institutional18.65%
Ent. value23.46B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out252.88M
Employees7.81K
ListedThu, Oct 10, 2019
Free float107.62M
Float %42.8%
Short interest2.27M
Days to cover2.9d
Short volume19.5%
Squeeze score19 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$3.03 vs −$2.58
Last surprise-17.4% miss
Setup gradeD
Conviction25 / 100
Pattern quality—
Tech rank35.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance96.61
Support88.35
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in BNTX · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Valerie Hoyle house · D · OR · traded 2025-08-07 | Sell | $1K–$15K | 2025-08-07 | 2025-09-12 |
Insider activity
SEC Form 4 transactions in BNTX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Jimenez Kylie Chief People Officer · Performance Share Unit · 2026-05-12 | Grant | 8.39K | $0 | 2026-05-12 | 2026-05-13 |
Jimenez Kylie Chief People Officer · Option (right to buy) · 2026-05-12 | Grant | 10.49K | $0 | 2026-05-12 | 2026-05-13 |
Zapata Gomez Ramon Chief Financial Officer · Option (right to buy) · 2026-05-12 | Grant | 18.88K | $0 | 2026-05-12 | 2026-05-13 |
Zapata Gomez Ramon Chief Financial Officer · Performance Share Unit · 2026-05-12 | Grant | 15.1K | $0 | 2026-05-12 | 2026-05-13 |
Ryan James Timothy Patrick See remarks. · Option (right to buy) · 2026-05-12 | Grant | 12.59K | $0 | 2026-05-12 | 2026-05-13 |
Ryan James Timothy Patrick See remarks. · Performance Share Unit · 2026-05-12 | Grant | 10.07K | $0 | 2026-05-12 | 2026-05-13 |
Poetting Sierk Chief Operating Officer · Option (right to buy) · 2026-05-12 | Grant | 12.59K | $0 | 2026-05-12 | 2026-05-13 |
Hanekamp Annemarie Chief Commercial Officer · Option (right to buy) · 2026-05-12 | Grant | 12.59K | $0 | 2026-05-12 | 2026-05-13 |
Poetting Sierk Chief Operating Officer · Performance Share Unit · 2026-05-12 | Grant | 10.07K | $0 | 2026-05-12 | 2026-05-13 |
Hanekamp Annemarie Chief Commercial Officer · Performance Share Unit · 2026-05-12 | Grant | 10.07K | $0 | 2026-05-12 | 2026-05-13 |
SEC filings
EDGAR filings in BNTX · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.